← Eichor
Study identifier: NCT04454177 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

SMART Watch Facilitated Early Discharge in Patients Undergoing Transcatheter Aortic Valve Replacement

Condition: Aortic Stenosis · Valvular Heart Disease · Transcatheter Aortic Valve Replacement  ·  Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this study is to observe conduction disturbance, daily activity level, heart rates, oxygen saturation in patients who underwent Transcatheter Aortic Valve Replacement (TAVR) and to evaluate the utility of the HUAWEI Watch (HUAWEI Technologies Co., Ltd., Shenzhen, China) for the potential early warning sign of changes in multiple biometric parameters including heart rate, rhythm, oxygen saturation, activity, and sleep in patients following TAVR. This will be evaluated in the context of a recently implemented early discharge protocol.

This description comes directly from the study's public registry record.

Talk to the study team

Jiaqi Fan, MD  ·  +86-15267029492  ·  fanjiaqi@zju.edu.cn

Xianbao Liu, MD, PhD  ·  +86-13857173887  ·  liuxb2009@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityHangzhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04454177